Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  NuPathe Inc    

NUPATHE INC
Mes dernières consult.
Most popular
Report
 SummaryNewsCalendarCompanyFinancials 
Company
NuPathe, Inc. develops pharmaceutical and therapeutic products.The firm focuses on the development and commercialization of branded therapeutics for diseases of the central nervous system, including neurological and psychiatric disorders.The company was founded by Terri B. Sebree and Jane H.... 
Sector
Pharmaceuticals
Calendar
-
More about the company
Latest news on NUPATHE INC
2014DJU.S. HOT STOCKS : Hot Stocks to Watch
2014 NUPATHE INC : Endo Merger Agreement with NuPathe Terminated
2014 NuPathe Terminates Agreement With Endo and Enters Into Agreement to Be Acquir..
2014 NUPATHE INC : NuPathe Inc. Stockholders Encouraged to Contact Securities Law Fir..
2013 NUPATHE INC : Program Participations and Positive Stock Movements - Research Rep..
2013 NUPATHE INC : NUPATHE INVESTOR ALERT: Faruqi & Faruqi, LLP Announces the Investi..
2013 NUPATHE INC : INVESTOR ALERT Levi & Korsinsky, LLP Announces Investigation of NU..
2013 NUPATHE INC : Harwood Feffer LLP Announces Investigation of NuPathe, Inc.
2013 NUPATHE INC : PATH SHAREHOLDER ALERT: The Law Firm of Wohl & Fruchter is Investi..
2013 NUPATHE INC : SHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Announces In..
More news
Sector news : Pharmaceuticals - NEC
12/13 TEVA PHARMACEUTICAL INDUSTRIES : Fears of Israeli job cuts at Teva sparks call f..
12/13 France's Sanofi pins hopes on new drugs after setbacks
12/13DJELI LILLY AND : Sees Modest Revenue Growth in 2018
12/13 SANOFI : CEO says M&A targets in oncology are 'very expensive'
12/13DJPLANT IMPACT : Needs Extra GBP7 Million Funding by April, Hands up 'For Sale' Si..
More sector news : Pharmaceuticals - NEC
Income Statement Evolution
Managers
NameTitle
Richard S. Egosi President, Chief Executive Officer & Director
Deborah A. Griffin Chief Financial Officer, Treasurer, Director & VP
Austin D. Kim Secretary
Sector and Competitors
1st jan.Capitalization (M$)
NUPATHE INC0
JOHNSON & JOHNSON21.53%379 175
NOVARTIS12.01%218 773
PFIZER10.04%215 837
ROCHE HOLDING LTD.3.40%209 423
MERCK AND COMPANY-6.96%153 659